Old Drug, New Pain. Roles and Challenges of Methadone Therapy in Pediatric Palliative Care: A Systematic Review.

children life limiting disease methadone opioids pain pediatric palliative care (PPC)

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2022
Historique:
received: 12 02 2022
accepted: 04 05 2022
entrez: 17 6 2022
pubmed: 18 6 2022
medline: 18 6 2022
Statut: epublish

Résumé

Pediatric palliative care (PPC) is defined as the prevention and relief from suffering of families and children with life-limiting (LLDs) or life-threatening diseases (LTDs). These patients often experience pain, with morphine being the most widely used drug to treat it. Few studies investigated the role of methadone in PPC patients, although it is considered among the most effective and underutilized drugs in PPC. Our aim was to evaluate the efficacy, safety, and dosage of methadone in PPC. Between August and October 2021 PubMed, Scopus and the Cochrane Library were searched for studies on the use of methadone in children with LLDs and LTDs. Articles were included if they met the following criteria: published in the last 10 years, English language, patients aged 0-23 years; children enrolled in a PPC center or receiving declared support from a PPC service; reporting of specific data on methadone in interventional trials, observational studies, or case series on >10 patients. The reporting of the article was guided by the PRISMA guidelines, and a critical appraisal of the included studies was performed using the JBI-tool. After duplicates removal and full-text assessment, four studies were included and another one was added after checking the references of the retrieved papers. All were retrospective, and the literature is concordant in documenting the lack of evidence. A total of 116 children received methadone in PPC. From our review emerges the poor quality of data collection: in only one study pain was assessed with standardized scales. All studies documented the effectiveness of methadone in treating complex pain, either nociceptive or neuropathic. No serious adverse events were reported, with no cases of cardiac arrhythmias. Our results suggest that methadone could represent a suitable strategy for treating pain in PPC. However, the evidence base is insufficient, and further research is warranted.

Sections du résumé

Background UNASSIGNED
Pediatric palliative care (PPC) is defined as the prevention and relief from suffering of families and children with life-limiting (LLDs) or life-threatening diseases (LTDs). These patients often experience pain, with morphine being the most widely used drug to treat it. Few studies investigated the role of methadone in PPC patients, although it is considered among the most effective and underutilized drugs in PPC.
Objectives UNASSIGNED
Our aim was to evaluate the efficacy, safety, and dosage of methadone in PPC.
Methods UNASSIGNED
Between August and October 2021 PubMed, Scopus and the Cochrane Library were searched for studies on the use of methadone in children with LLDs and LTDs. Articles were included if they met the following criteria: published in the last 10 years, English language, patients aged 0-23 years; children enrolled in a PPC center or receiving declared support from a PPC service; reporting of specific data on methadone in interventional trials, observational studies, or case series on >10 patients. The reporting of the article was guided by the PRISMA guidelines, and a critical appraisal of the included studies was performed using the JBI-tool.
Results UNASSIGNED
After duplicates removal and full-text assessment, four studies were included and another one was added after checking the references of the retrieved papers. All were retrospective, and the literature is concordant in documenting the lack of evidence. A total of 116 children received methadone in PPC. From our review emerges the poor quality of data collection: in only one study pain was assessed with standardized scales. All studies documented the effectiveness of methadone in treating complex pain, either nociceptive or neuropathic. No serious adverse events were reported, with no cases of cardiac arrhythmias.
Conclusion UNASSIGNED
Our results suggest that methadone could represent a suitable strategy for treating pain in PPC. However, the evidence base is insufficient, and further research is warranted.

Identifiants

pubmed: 35712616
doi: 10.3389/fped.2022.874529
pmc: PMC9196103
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

874529

Informations de copyright

Copyright © 2022 Benedetti, Zoletto, Salerno, Avagnina and Benini.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Clin J Pain. 2019 Jun;35(6):501-508
pubmed: 30985399
Am Fam Physician. 2005 Apr 1;71(7):1353-8
pubmed: 15832538
Cochrane Database Syst Rev. 2017 Jul 26;7:CD012538
pubmed: 28745394
Pediatr Blood Cancer. 2015 Jul;62(7):1237-44
pubmed: 25820345
J Palliat Med. 2018 Sep;21(9):1317-1321
pubmed: 29664690
J Opioid Manag. 2016 May-Jun;12(2):123-30
pubmed: 27194197
J Pain Symptom Manage. 2015 Aug;50(2):248-59.e1
pubmed: 25896106
Schmerz. 2008 Aug;22(4):401-8
pubmed: 18516628
Am J Hosp Palliat Care. 2008 Apr-May;25(2):146-50
pubmed: 18445864
Indian J Palliat Care. 2021 Jan-Mar;27(1):133-138
pubmed: 34035631
Prim Care. 2019 Sep;46(3):461-473
pubmed: 31375193
Cochrane Database Syst Rev. 2015 Mar 13;(3):CD010750
pubmed: 25768935
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Am J Hosp Palliat Care. 2021 Aug;38(8):914-919
pubmed: 33000633
Acad Pediatr. 2018 May - Jun;18(4):376-383
pubmed: 29229566
Paediatr Drugs. 2009;11(2):129-51
pubmed: 19301934
J Pain. 2014 Apr;15(4):321-37
pubmed: 24685458
Children (Basel). 2018 Jun 27;5(7):
pubmed: 29954057
J Pain Symptom Manage. 2015 May;49(5):923-7
pubmed: 25546288
Pediatr Clin North Am. 2007 Oct;54(5):645-72, x
pubmed: 17933616
Dev Med Child Neurol. 2016 Apr;58(4):395-401
pubmed: 26510627
J Pain Symptom Manage. 2022 May;63(5):e529-e543
pubmed: 35031506
J Clin Psychol Med Settings. 2021 Dec;28(4):781-788
pubmed: 33598787
Drugs. 2020 Feb;80(2):115-130
pubmed: 31820362
JBI Evid Synth. 2020 Oct;18(10):2127-2133
pubmed: 33038125
J Pain Res. 2017 Jul 31;10:1841-1852
pubmed: 28831272
Pediatr Blood Cancer. 2015 Jun;62(6):1087-90
pubmed: 25641929
Eur J Drug Metab Pharmacokinet. 2019 Oct;44(5):591-609
pubmed: 31006834
Paediatr Drugs. 2018 Oct;20(5):409-416
pubmed: 30047027
Cochrane Database Syst Rev. 2017 Jul 19;7:CD012564
pubmed: 28722116
Pediatr Blood Cancer. 2008 Sep;51(3):393-7
pubmed: 18428431
Pediatrics. 2017 Jun;139(6):
pubmed: 28562301
Ann Intern Med. 2009 Mar 17;150(6):387-95
pubmed: 19153406
J Pain Symptom Manage. 2014 Nov;48(5):903-14
pubmed: 24703942

Auteurs

Francesca Benedetti (F)

Pediatric Residency Program, University of Padova, Padova, Italy.

Silvia Zoletto (S)

Pediatric Residency Program, University of Padova, Padova, Italy.

Annalisa Salerno (A)

Pediatric Residency Program, University of Padova, Padova, Italy.

Irene Avagnina (I)

Pediatric Pain and Palliative Care Service, Department of Women's and Children's Health, University Hospital of Padova, Padova, Italy.

Franca Benini (F)

Pediatric Pain and Palliative Care Service, Department of Women's and Children's Health, University Hospital of Padova, Padova, Italy.

Classifications MeSH